490 related articles for article (PubMed ID: 25664445)
21. [Analysis of immunophenotypic features of blasts in patients with myelodysplastic syndrome by flow cytometry and its diagnostic significance].
Sun JF; Yang B; Zhang L; Huang Y; Yang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):632-5. PubMed ID: 22739171
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
[TBL] [Abstract][Full Text] [Related]
23. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
24. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
[TBL] [Abstract][Full Text] [Related]
25. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
26. [Four-color flow cytometric immunophenotypic features of blasts in myelodysplastic syndromes].
Wu YJ; Li JY; Qiu HR; Xiao B; Zhang JF; Song JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):50-3. PubMed ID: 16584591
[TBL] [Abstract][Full Text] [Related]
27. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
28. Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms.
Jevremovic D; Timm MM; Reichard KK; Morice WG; Hanson CA; Viswanatha DS; Howard MT; Nguyen PL
Am J Clin Pathol; 2014 Sep; 142(3):292-8. PubMed ID: 25125617
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of non-lymphoid cells.
Pattanapanyasat K; Kyle DE; Tongtawe P; Yongvanitchit K; Fucharoen S
Cytometry; 1994 Dec; 18(4):199-208. PubMed ID: 7534676
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
[TBL] [Abstract][Full Text] [Related]
31. One tube with eight antibodies for 14-part bone marrow leukocyte differential using flow cytometry.
Jacob MC; Souvignet A; Pont J; Solly F; Mondet J; Kesr S; Pernollet M; Dumestre-Perard C; Campos L; Cesbron JY
Cytometry B Clin Cytom; 2017 Jul; 92(4):299-309. PubMed ID: 26990701
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a 10color protocol as part of a 2tube screening panel for flow cytometric assessment of peripheral blood leukocytic subsets.
Gounari E; Tsavdaridou V; Ioakeimidou A; Haidich AB; Skoura L
Scand J Clin Lab Invest; 2019 Nov; 79(7):475-483. PubMed ID: 31497995
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
Della Porta MG; Lanza F; Del Vecchio L;
Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
[TBL] [Abstract][Full Text] [Related]
34. Novel lymphocyte screening tube using dried monoclonal antibody reagents.
Hedley BD; Keeney M; Popma J; Chin-Yee I
Cytometry B Clin Cytom; 2015; 88(6):361-70. PubMed ID: 25944189
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.
Schenker EL; Hultin LE; Bauer KD; Ferbas J; Margolick JB; Giorgi JV
Cytometry; 1993; 14(3):307-17. PubMed ID: 8472607
[TBL] [Abstract][Full Text] [Related]
36. Ten-color 15-antibody flow cytometry panel for immunophenotyping of lymphocyte population.
Rajab A; Axler O; Leung J; Wozniak M; Porwit A
Int J Lab Hematol; 2017 May; 39 Suppl 1():76-85. PubMed ID: 28447425
[TBL] [Abstract][Full Text] [Related]
37. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
38. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
[TBL] [Abstract][Full Text] [Related]
39. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Bardet V; Wagner-Ballon O; Guy J; Morvan C; Debord C; Trimoreau F; Benayoun E; Chapuis N; Freynet N; Rossi C; Mathis S; Gourin MP; Toma A; Béné MC; Feuillard J; Guérin E; ;
Haematologica; 2015 Apr; 100(4):472-8. PubMed ID: 25637056
[TBL] [Abstract][Full Text] [Related]
40. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
